HSandM Magazine

Menu
  • Home
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
  • Advertise
  • Agency Directory
  • Showcase your Innovations
  • FREE SUBSCRIPTION!
Menu

HSandM Magazine

Search

Nov/Dec2019

Latest stories

INDUSTRY TRENDS: BY THE NUMBERS

TOP 100 HEALTHCARE COMPANIES

Talent Trends: Keeping Yourself Safe When Navigating the Salary Ban

More stories

  • in Motivideos

    MOTIVIDEOS

    by hsandm November 1, 2019, 12:00 pm

  • in Innovation Showcase

    The Cleveland Clinic Top 10 Innovations

    by hsandm November 1, 2019, 12:00 pm

  • in Industry Trends

    KPMG REPORT ON MEDICAL DEVICES 2030

  • in Round Table

    THE REGULATORY ATMOSPHERE: Execs From Smiths, Transenterix, Bausch and Tandem Offer Insights

    by hsandm November 1, 2019, 12:00 pm

  • in Executive Spotlight

    Olympus Executive Director of Marketing, Peter Crowley, on Improving Patient Outcomes by Keeping the Focus on People

    by hsandm November 1, 2019, 12:00 pm

  • in Great Minds

    Senior Sales Director at Lilly and Company on the Lessons He Learned in War

    by hsandm November 1, 2019, 12:00 pm

  • in Digital Magazine

    November / December 2019

    by hsandm November 1, 2019, 12:00 pm

Trending Now

  • Headlines

    815 Views0 Comments

    in Headlines

    Charles River Dives Deep Into Cell and Gene Therapy With Cognate BioServices Acquisition

    Wilmington, MA , February 17 2021 (Business Wire) — Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has signed a definitive agreement to acquire Cognate BioServices, Inc., a premier, cell and gene therapy contract development and manufacturing organization (CDMO), for approximately $875 million in cash, subject to customary closing adjustments. The transaction is expected to close by the end of the first quarter of 2021, subject to regulatory requirements and customary closing conditions. More

    by hsandm February 17, 2021, 7:13 pm

    Read More

  • Headlines

    431 Views0 Comments

    in Headlines

    Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious Disease Programs

    San Francisco, CA, February 17, 2021 (GLOBE NEWSWIRE) — Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the completion of a $60 million financing. The proceeds will be used to advance Excision’s lead candidate, EBT-101, into a Phase 1/2 clinical trial in patients with chronic HIV infection. The financing will also support preclinical programs including EBT-103 targeting JC Virus for Progressive Multifocal Leukoencephalopathy (PML), EBT-104 for Herpes Simplex Virus, and EBT-107 for Hepatitis B. More

    by hsandm February 17, 2021, 6:51 pm

    Read More

  • Headlines

    1 Shares712 Views0 Comments

    in Headlines

    Henry Schein One Appoints New Chief Executive Officer

    American Fork, UT, February 16, 2021 (BUSINESS WIRE) — Henry Schein One, a joint venture of Henry Schein, Inc., and Internet Brands, has announced that Mike Baird will assume the role of Chief Executive Officer, leading all aspects of Henry Schein One’s business. In his new role of CEO, Mr. Baird will lead the organization in driving growth, developing more seamlessly integrated products, and advancing digital innovations that help customers build stronger practices and deliver quality care. More

    by hsandm February 16, 2021, 7:37 pm

    Read More

  • Headlines

    902 Views0 Comments

    in Headlines

    Boehringer Ingelheim Animal Health USA Establishes Pawru, Inc.

    Duluth, GA., February 16, 2021 (PRNewswire) — Boehringer Ingelheim Animal Health USA Inc. today announced the creation of Pawru, Inc. as a separate Company within the Boehringer Ingelheim Animal Health business. More

    by hsandm February 16, 2021, 6:27 pm

    Read More

  • Headlines

    803 Views0 Comments

    in Headlines

    AIkido Pharma Inc. Announces $10 Million Bought Deal Offering Of Common Stock

    New York NY, February 16 2021 (PRNewswire) — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 6,250,000 shares of common stock of the Company at a price to the public of $1.60 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about February 19, 2021, subject to satisfaction of customary closing conditions. More

    by hsandm February 16, 2021, 6:17 pm

    Read More

  • Headlines

    672 Views0 Comments

    in Headlines

    Jim Schuermann, 25 Year Industry Veteran, Appointed President & Chief Executive Officer of Saluda Medical

    Artarmon, Australia, February 12, 2021 (PRNewswire) — Saluda Medical Pty Limited (“Saluda Medical”), the market leader in the development of novel closed-loop spinal cord stimulation (SCS) for the treatment of chronic pain, today announced the appointment of Jim Schuermann as President & Chief Executive Officer. Mr. Schuermann joined Saluda Medical as President in June 2020. The company also announced that founder and CEO John Parker, PhD, will take on the new role of Chief Scientific Officer, while remaining on the company’s Board of Directors. More

    by hsandm February 12, 2021, 3:48 pm

    Read More

Categories

  • Agency Directory
  • Digital Magazine
  • Editorial Board
  • Executive Spotlight
  • Great Minds
  • Headlines
  • Industry Trends
  • Innovation Showcase
  • Leadership
  • Motivideos
  • Round Table
  • Talent Trends
  • Top Industry Lists
  • Uncategorized
  • Why I Work in Healthcare

© 2021 by CL Media, Inc.

  • Home
  • Contact us
  • GDPR Privacy policy
  • Privacy Policy
  • Terms of Use
  • Sign Up!
Back to Top
Close
  • Home
  • Headlines
  • Top Articles
    • Executive Spotlights
    • Round Tables
    • Industry Trends
    • Talent Trends
    • Great Minds
    • Innovation Showcase
    • Top Industry Lists
  • Advertise
  • Agency Directory
  • Showcase your Innovations
  • FREE SUBSCRIPTION!
  • facebook
  • twitter
  • instagram
  • pinterest
  • youtube

Log In

Sign In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Back to Login

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

To use social login you have to agree with the storage and handling of your data by this website. %privacy_policy%

Accept

Add to Collection

  • Public collection title

  • Private collection title

No Collections

Here you'll find all collections you've created before.